Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mint Med vs Sprout Health

Mint Med
Graded #22

Lower grade

vs+1.7000000000000028
Sprout Health
Graded #6

Higher grade

The verdict

Sprout Health takes it — 86.4/100 to 84.7/100, but only just.

Sprout Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start. Mint Med is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
90
90
Dose & formulationSprout Health +2
80
82
Clinical oversightSprout Health +3
85
88
Labs & monitoringSprout Health +9
83
92
FulfillmentMint Med +4
82
78
Contract termsMint Med +2
86
84
Mint Med · left barSprout Health · right bar

The numbers

MetricMint MedSprout Health
WeighScore84.7/10086.4/100
GradeBB
Scorecard rank#22#6
Semaglutide$117/mo$149/mo
Tirzepatide$159/mo$199/mo
Coverage36 statesNot disclosed
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Mint Med

Graded #22 · B

Strengths

  • $117 sema / $159 tirz
  • LegitScript-verified
  • Both molecules

Where it loses points

  • Only 36 states
  • Injection-only
  • Monitoring detail sparse
Sprout Health

Graded #6 · B

Strengths

  • LegitScript-certified with a listed address and contact line
  • Both compounded ($149 semaglutide / $199 tirzepatide) and a genuine brand-name Wegovy/Zepbound route
  • Low-friction intake — no labs and often no telehealth visit required

Where it loses points

  • Compounded semaglutide and tirzepatide are not FDA-approved
  • No oral or sublingual route — injectable only
  • Thin transparency — no named medical director, and state availability is quiz-gated
  • "No labs, no visit" convenience also means lighter clinical oversight

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard